New Boston Research Hub
Roche and Genentech Open New Boston Research Center for Advanced Drug Discovery
Anonymous
Roche and its Genentech subsidiary have opened the Roche Genentech Innovation Center Boston in Allston’s Harvard Enterprise Research Campus, expanding the companies’ U.S. research operations. The 95,000-square-foot facility, covered by a 10-year lease and designed to accommodate up to 500 employees, will serve as Roche’s hub for cardiovascular, renal and metabolic research. Scientists in discovery research, clinical development, artificial intelligence and data science will work across the full drug-development process, from early discovery through late-stage clinical trials. The center is intended to connect Roche and Genentech with Boston’s universities, biotech companies and scientific talent while complementing research teams in South San Francisco and Basel. The opening forms part of the companies’ stated $50 billion commitment to U.S. manufacturing and research and development, alongside investments in North Carolina and Oregon.
Key Points
1
Roche and Genentech said the CVRM focus will address interconnected conditions—including obesity and type 2 diabetes, metabolic dysfunction-associated steatohepatitis (MASH), hypertension and cardiovascular disease—by studying shared biology and pursuing more integrated, personalized treatments.
2
The companies cited prior work involving efforts to combat antibiotic-resistant bacteria and the use of artificial intelligence in cancer research to identify targeted treatment approaches and assess drug effectiveness in clinical trials.
3
Boston Mayor Michelle Wu said the center would create hundreds of jobs, attract new investment and further strengthen the city’s life-sciences ecosystem, calling the companies’ arrival a boost to Boston’s innovation leadership.
4
The facility anchors the first phase of the Harvard Enterprise Research Campus, a nine-acre development led by Tishman Speyer and Breakthrough Properties in partnership with the Harvard Allston Land Company.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
6
Articles
12
Reach
18
A
AnonymousAuthor
